Literature DB >> 27974245

RhoA GTPase oxidation stimulates cell proliferation via nuclear factor-κB activation.

Jae-Gyu Kim1, Hyung-Joo Kwon2, Guang Wu3, Yohan Park1, Jae-Yong Lee4, Jaebong Kim4, Sung-Chan Kim4, Myoen Choe5, Seung Goo Kang6, Goo-Young Seo7, Pyeung-Hyeun Kim7, Jae-Bong Park8.   

Abstract

Reactive oxygen species (ROS) produced by many kinds of stimuli are essential for cellular signaling including cell proliferation. The dysregulation of ROS, therefore, is related to a variety of diseases including cancer. However, it was not clearly elucidated how ROS regulate cell proliferation and tumorigenesis. In this study, we investigated a mechanism by which the oxidation of RhoA GTPase regulates nuclear factor-κB (NF-κB) and cell proliferation. Hydrogen peroxide activated NF-κB and RhoA GTPase, but did not activate RhoA C16/20A mutant, an oxidation-resistant form. Remarkably, the oxidation of RhoA reduced its affinity towards RhoGDI, leading to the dissociation of RhoA-RhoGDI complex. Si-Vav2, a guanine nucleotide exchange factor (GEF), inhibited RhoA activation upon hydrogen peroxide. The oxidized RhoA (oxRhoA)-GTP was readily bound to IκB kinase γ (IKKγ), whereas oxidized RhoGDI did not bind to IKKγ. The oxRhoA-GTP bound to IKKγ activated IKKβ, leading to IκB phosphorylation and degradation, consequently NF-κB activation. Hydrogen peroxide induced cell proliferation, but RhoA C16/20A mutant suppressed cell proliferation and tumorigenesis. Conclusively, RhoA oxidation at Cys16/20 is critically involved in cell proliferation and tumorigenesis through NF-κB activation in response to ROS.
Copyright © 2016. Published by Elsevier Inc.

Entities:  

Keywords:  Cell proliferation; NF-κB; Oxidation; RhoA; Tumor

Mesh:

Substances:

Year:  2016        PMID: 27974245     DOI: 10.1016/j.freeradbiomed.2016.12.013

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  8 in total

Review 1.  Underappreciated roles for Rho GDP dissociation inhibitors (RhoGDIs) in cell function: Lessons learned from the pancreatic islet β-cell.

Authors:  Anjaneyulu Kowluru; Noah F Gleason
Journal:  Biochem Pharmacol       Date:  2021-12-28       Impact factor: 5.858

Review 2.  RhoA Signaling in Neurodegenerative Diseases.

Authors:  Sissel Ida Schmidt; Morten Blaabjerg; Kristine Freude; Morten Meyer
Journal:  Cells       Date:  2022-05-01       Impact factor: 7.666

3.  Pyruvate Dehydrogenase A1 Phosphorylated by Insulin Associates with Pyruvate Kinase M2 and Induces LINC00273 through Histone Acetylation.

Authors:  Abu Jubayer Hossain; Rokibul Islam; Jae-Gyu Kim; Oyungerel Dogsom; Kim Cuong Cap; Jae-Bong Park
Journal:  Biomedicines       Date:  2022-05-27

4.  The Emerging Roles of Nicotinamide Adenine Dinucleotide Phosphate Oxidase 2 in Skeletal Muscle Redox Signaling and Metabolism.

Authors:  Carlos Henríquez-Olguín; Susanna Boronat; Claudio Cabello-Verrugio; Enrique Jaimovich; Elena Hidalgo; Thomas E Jensen
Journal:  Antioxid Redox Signal       Date:  2019-11-01       Impact factor: 8.401

Review 5.  Regulation of RhoA GTPase and novel target proteins for ROCK.

Authors:  Eun-Kyoung Choi; Jae-Gyu Kim; Hee-Jun Kim; Jung-Yoon Cho; Hwalrim Jeong; Yohan Park; Rokibul Islam; Cuong Kim Cap; Jae-Bong Park
Journal:  Small GTPases       Date:  2017-12-03

Review 6.  New insights into RhoA/Rho-kinase signaling: a key regulator of vascular contraction.

Authors:  Kenia Pedrosa Nunes; R Clinton Webb
Journal:  Small GTPases       Date:  2020-09-24

7.  VAV2 is required for DNA repair and implicated in cancer radiotherapy resistance.

Authors:  Weiling Liu; Chuanwang Miao; Shaosen Zhang; Yachen Liu; Xiangjie Niu; Yiyi Xi; Wenjia Guo; Jiahui Chu; Ai Lin; Hongjin Liu; Xinyu Yang; Xinjie Chen; Ce Zhong; Yuling Ma; Yuqian Wang; Shihao Zhu; Shuning Liu; Wen Tan; Dongxin Lin; Chen Wu
Journal:  Signal Transduct Target Ther       Date:  2021-08-30

Review 8.  Regulation of Rho GTPases by RhoGDIs in Human Cancers.

Authors:  Hee Jun Cho; Jong-Tae Kim; Kyoung Eun Baek; Bo-Yeon Kim; Hee Gu Lee
Journal:  Cells       Date:  2019-09-05       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.